Clinical Trials
20 trialsNCT01118676 2026-04-14
Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer
Institut Claudius Regaud
Phase 1 Completed
NCT01165333 2026-03-16
CILENT
Centre Oscar Lambret
Phase 1 Completed
NCT00884598 2024-05-10
CIRAB
Universitätsmedizin Mannheim
Phase 1 Completed
NCT00093964 2019-04-16
Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)
EMD Serono
Phase 2 Completed
NCT00679354 2018-08-01
Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
National Cancer Institute (NCI)
Phase 2 Completed
NCT00813943 2017-01-30
CORE
EMD Serono
Phase 2 Completed
NCT00842712 2017-01-13
CERTO
Merck KGaA, Darmstadt, Germany
Phase 2 Completed
NCT00121238 2016-04-28
Cilengitide in Treating Patients With Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01276496 2016-03-15
Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Phase 1 Completed
NCT00085254 2016-02-25
Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT00979862 2015-04-15
Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma
National Cancer Institute (NCI)
Phase 1 Completed
NCT00689221 2014-11-04
CENTRIC
EMD Serono
Phase 3 Completed
NCT00004258 2014-09-17
EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer
Indiana University
Phase 1 Completed
NCT00705016 2014-04-30
ADVANTAGE
Merck KGaA, Darmstadt, Germany
Phase 1/2 Completed
NCT01504165 2014-02-04
Pharmacokinetics in Subjects With Renal Impairment
Merck KGaA, Darmstadt, Germany
Phase 1 Completed
NCT00063973 2013-09-30
Cilengitide in Treating Children With Refractory Primary Brain Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00006093 2013-06-24
EMD 121974 in Treating Patients With Progressive or Recurrent Glioma
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT00103337 2013-02-28
Cilengitide in Treating Patients With Metastatic Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00022113 2013-01-25
EMD 121974 in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00077155 2013-01-24
Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma
National Cancer Institute (NCI)
Phase 1 Completed